Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results
11/05/2026 23:39
May 11 (Reuters) - Turn Therapeutics Inc TTRX.O: TURN THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES TURN THERAPEUTICS INC - Q1 NET LOSS PER SHARE $0.03 Source text: ID:nBwb0nCxda Further company coverage: TTRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Turn Therapeutics
See all newsTurn Therapeutics Q2 net loss per share widens on higher R&D costs
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Turn Therapeutics Reports Interim Analysis Findings And Adaptive Optimization Strategy From Phase 2 GX-03 Trial In Moderate-To-Severe Atopic Dermatitis
Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results